Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
MIAMI, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Founded by Branden Condy, ProtectMyBrand is a newly launched online reputation management firm designed to help individuals, executives, and companies...
Read More -
The final hours of fixed-price distribution conclude as the project transitions from allocation to live market execution. HELSINKI, Finland, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin Munari is...
Read More
-
MIAMI, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Founded by Branden Condy, ProtectMyBrand is a newly launched online reputation management firm designed to help individuals, executives, and companies...
-
BENTONVILLE, Ark., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today...
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI Hardware Market Till 2035: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global AI hardware...
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI Chip Market, Till 2035: Distribution by Type of Chip, Type of Processing, Type of Technology, Type of Function, Type of Application, Type of...
-
Visa,a global leader in digital payments, released its annual Retail Spend Monitor from Visa Consulting & Analytics, offering insight into Canada’s holiday
-
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an...
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Agriculture Robots Market, Till 2035: Distribution by Type of Robot, Type of Offering, Type of Farming Environment, Type of Farm Products, Type of...
-
23 December 2025 Notification no. 86/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with...
-
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single...
-
The final hours of fixed-price distribution conclude as the project transitions from allocation to live market execution. HELSINKI, Finland, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin Munari is...